Table 3.
Antibiotics received during hospitalization in hospitalized patients with sepsis, statin group and control group.
| Antibiotics received | All patients (n=345) |
Statin group (n=102) |
Control group (n=243) |
p-value |
|---|---|---|---|---|
| Number of antibiotics | 4.52±2.43 | 5.16±2.62 | 4.25±2.3 | 0.03 |
| Imipenem/cislatin or Tienam® | 228 (66.1%) | 77 (75.5%) | 151 (66.6%) | 0.017 |
| Vancomycin | 181 (52.5%) | 54 (52.9%) | 127 (52.7%) | 0.908 |
| Amikacin | 143 (41.4%) | 44 (43.1%) | 99 (44.7%) | 0.68 |
| Métronidazole ou Flagyl® | 126 (36.5%) | 39 (38.5%) | 87 (35.8%) | 0.668 |
| Tazocin | 96 (27.8%) | 31 (30.4%) | 65 (26.7%) | 0.491 |
| Ciprofloxacin | 95 (27.5%) | 39 (38.2%) | 56 (23%) | 0.004 |
| Colimycin | 93 (27%) | 30 (31.4%) | 62 (25.5%) | 0.351 |
| Levofloxacin or Tavanic® | 69 (20%) | 24 (23.5%) | 45 (18.5%) | 0.288 |
| Moxifloxacin or Avalox® | 55 (15.9%) | 21 (20.6%) | 34 (14%) | 0.127 |
| Tigecyclin or Tigacyl® | 52 (15.1%) | 16 (15.7%) | 36 (14.8%) | 0.836 |
| Amoxicillin | 50 (14.5%) | 21 (20.6%) | 29 (11.9%) | 0.037 |
| Meropenem or Meronem® | 47 (13.6%) | 12 (11.8%) | 35 (14.4%) | 0.514 |
| Ceftriaxon or Triaxone® | 45 (13%) | 41(40.2%) | 74 (30.5%) | 0.08 |
| Ceftazidim or Fortum® | 45 (13%) | 12 (11.8%) | 33 (13.6%) | 0.648 |
| Teicoplamin or Targocid® | 43 (12.5%) | 18 (17.6%) | 25 (10.3%) | 0.059 |
| Other antibiotics* | 104 (30.1%) | 38 (37.3%) | 66 (27.2%) | 0.062 |
| *cefipim, ampicillin, cefuroxim, Arithromycin, claritromycin and clindamycin. | ||||